Home » Topics » BioWorld Science

BioWorld Science
RSS

XR-9051: MDR-reversing agent

June 14, 1996

Fujisawa reveals FR-177391, agent for cachexia in cancer patients

June 14, 1996

PN 27.1 compassionate use trial broadened

June 14, 1996

Actimmune metastatic renal cell carcinoma development terminated

June 14, 1996

ZK-138723: Schering AG's aromatase inhibitor

June 14, 1996

RPR's Taxotere available in the U.S.

June 14, 1996

Navelbine on Canadian market

June 14, 1996

The Salk Institute for Biological Studies reveals immunophilin proteins

June 14, 1996

Astra reports autoimmune disease treatment agents

June 14, 1996

Generic formulation of Feldene approved

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...